2,4-thiazolidinedione has been researched along with Cancer of the Thyroid in 3 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anaplastic thyroid carcinoma is an aggressive neoplasm and resistant to all sorts of treatment due to its rapid growth and invasive potential." | 1.32 | Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma. ( Amino, N; Hayashi, N; Hiraoka, N; Monden, M; Nakamori, S; Sakon, M; Takano, T; Tsujie, M; Xundi, X, 2004) |
| "Poorly differentiated, metastatic thyroid cancer is difficult to treat." | 1.32 | Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment. ( Baumbusch, MA; Haugen, BR; Hays, WR; Hershman, JM; Klopper, JP; Sharma, V, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, N | 1 |
| Nakamori, S | 1 |
| Hiraoka, N | 1 |
| Tsujie, M | 1 |
| Xundi, X | 1 |
| Takano, T | 1 |
| Amino, N | 1 |
| Sakon, M | 1 |
| Monden, M | 1 |
| Klopper, JP | 1 |
| Hays, WR | 1 |
| Sharma, V | 1 |
| Baumbusch, MA | 1 |
| Hershman, JM | 1 |
| Haugen, BR | 1 |
| Kroll, TG | 1 |
| Sarraf, P | 1 |
| Pecciarini, L | 1 |
| Chen, CJ | 1 |
| Mueller, E | 1 |
| Spiegelman, BM | 1 |
| Fletcher, JA | 1 |
3 other studies available for 2,4-thiazolidinedione and Cancer of the Thyroid
| Article | Year |
|---|---|
Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Cell Differentiation; Cell Division; | 2004 |
Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Humans; Immunoprecipitation; Lig | 2004 |
PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
Topics: Adenocarcinoma, Follicular; Adenoma; Adult; Aged; Carcinoma, Papillary; Cell Line; Cell Nucleus; Chi | 2000 |